Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Uveal Melanoma 1Sarcoma 1Pancreatic Neoplasms 1Neurofibromatosis 2 1Myeloproliferative Disorders 1Multiple Myeloma 1Macular Degeneration 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Mycophenolic Acid 8Cyclophosphamide 8fludarabine phosphate 7Cyclosporine 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6Radiotherapy 5Cord Blood Stem Cell Transplantation 5Busulfan 5Antilymphocyte Serum 5Tacrolimus 4Methylprednisolone 4Methotrexate 3Granulocyte Colony-Stimulating Factor 3Whole-Body Irradiation 2Sunitinib 2Sirolimus 2Moxifloxacin 2Melphalan 2Ipilimumab 2Flow Cytometry 2Etoposide 2CTLA-4 Antigen 2Amplified Fragment Length Polymorphism Analysis 2venetoclax 1trametinib 1thymoglobulin 1sargramostim 1ruxolitinib 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × aflibercept × Clear all
NCT00509249 2015-01-08

Aflibercept in Treating Patients With Myelodysplastic Syndromes

National Cancer Institute (NCI)

Phase 2 Terminated
18 enrolled 4 charts
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡